The disappearing act of factor VIII
- PMID: 18771423
- DOI: 10.1111/j.1365-2516.2008.01864.x
The disappearing act of factor VIII
Abstract
Factor VIII (FVIII) is a plasma protein critical to the haemostatic system. This notion is illustrated by the severe bleeding disorder that is associated with its functional absence, known as haemophilia A. In addition, several epidemiological studies have revealed an association between the presence of elevated levels of FVIII and thrombotic complications. In view of its relation to thrombotic and haemorrhagic disorders, it is not surprising that FVIII has gained wide attention from the research community in the previous decades. This research has led to a better understanding of not only the structural, functional and physiological aspects of this intriguing protein, but also of the pathogenesis of haemostatic defects associated with FVIII. In the present review, focus will be on the interaction between FVIII and surface receptors that are able to capture FVIII. These interactions are of importance for FVIII, as they may affect both function and survival of FVIII.
Similar articles
-
Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance.Haemophilia. 2010 Jan;16(1):3-13. doi: 10.1111/j.1365-2516.2009.02005.x. Epub 2009 Apr 16. Haemophilia. 2010. PMID: 19473409 Review.
-
The factor VIII/von Willebrand factor complex: basic and clinical issues.Haematologica. 2003 Jun;88(6):EREP02. Haematologica. 2003. PMID: 12826528 Review.
-
Seminal Factor VIII and von Willebrand Factor: a possible role of the conventional clotting system in human semen?Int J Androl. 2005 Feb;28(1):31-8. doi: 10.1111/j.1365-2605.2004.00508.x. Int J Androl. 2005. PMID: 15679619
-
Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.Haemophilia. 2007 Dec;13 Suppl 5:61-4. doi: 10.1111/j.1365-2516.2007.01575.x. Haemophilia. 2007. PMID: 18078399 Review.
-
Regulated release of VWF and FVIII and the biologic implications.Pediatr Blood Cancer. 2006 May 1;46(5):547-53. doi: 10.1002/pbc.20658. Pediatr Blood Cancer. 2006. PMID: 16470522 Review.
Cited by
-
FVIII regulates the molecular profile of endothelial cells: functional impact on the blood barrier and macrophage behavior.Cell Mol Life Sci. 2022 Feb 21;79(3):145. doi: 10.1007/s00018-022-04178-5. Cell Mol Life Sci. 2022. PMID: 35190870 Free PMC article.
-
Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A.J Thromb Haemost. 2014 Apr;12(4):488-96. doi: 10.1111/jth.12506. J Thromb Haemost. 2014. PMID: 24843882 Free PMC article. Clinical Trial.
-
The Development of Acute Systemic Multiple Thrombosis after Achieving Remission during Systemic Glucocorticoid Therapy for Acquired Hemophilia A.Intern Med. 2018 Aug 1;57(15):2237-2241. doi: 10.2169/internalmedicine.0450-17. Epub 2018 Mar 9. Intern Med. 2018. PMID: 29526954 Free PMC article.
-
Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.AAPS J. 2014 Sep;16(5):1038-45. doi: 10.1208/s12248-014-9627-2. Epub 2014 Jun 17. AAPS J. 2014. PMID: 24934295 Free PMC article.
-
Lectin binding assays for in-process monitoring of sialylation in protein production.Mol Biotechnol. 2010 Jul;45(3):248-56. doi: 10.1007/s12033-010-9272-7. Mol Biotechnol. 2010. PMID: 20379804
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical